World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   1193 records for 304 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusMain ID Public TitleDate of Registration
Not RecruitingCTRI/2015/03/005597
To compare the effect of Tiotropium 5 ug and Olodaterol 5 ug in fixed dose combination over Tiotropium 5 ug in reducing Moderate to severe worsening of a disease in patients with severe to very severe Chronic Obstructive Pulmonary disease
02-03-2015
AuthorisedEUCTR2014-005241-45-FI
A Phase III Study of Pembrolizumab in Subjects with Gastric Cancer 20/02/2015
Not recruitingNCT02385773
Impact of the Nutritional Product PTM202 on Acute and Long-Term Recovery From Childhood Diarrheal Disease
06/02/2015
RecruitingNCT02348840
Perinatal mHealth Intervention in Guatemala
23/01/2015
AuthorisedEUCTR2014-002587-33-GB
Extension to the Odanacatib Fracture Trial (PN018)
02/12/2014
RecruitingNCT02307201
Magnesium Sulfate During the Postpartum in Women With Severe Preeclampsia
24/11/2014
Not recruitingNCT02301702
Maternal Tdap Immunization in Guatemala
22/11/2014
Not recruitingNCT02302729
Early Child Development and Nutrition in Guatemala
31/10/2014
AuthorisedEUCTR2014-002275-28-FI
Comparing the efficacy of tiotropium + olodaterol (5/5 µg) fixed dose combination (FDC) over tiotropium 5µg in reducing moderate to severe exacerbations in patients with severe to very severe Chronic Obstructive Pulmonary Disease.
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2014-002275-28-ATComparing the efficacy of tiotropium + olodaterol (5/5 µg) fixed dose combination (FDC) over tiotropium 5µg in reducing moderate to severe exacerbations in patients with severe to very severe Chronic Obstructive Pulmonary Disease.27/11/2014
AuthorisedEUCTR2014-002275-28-DKComparing the efficacy of tiotropium + olodaterol (5/5 µg) fixed dose combination (FDC) over tiotropium 5µg in reducing moderate to severe exacerbations in patients with severe to very severe Chronic Obstructive Pulmonary Disease.13/11/2014
AuthorisedEUCTR2014-002275-28-GRComparing the efficacy of tiotropium + olodaterol (5/5 µg) fixed dose combination (FDC) over tiotropium 5µg in reducing moderate to severe exacerbations in patients with severe to very severe Chronic Obstructive Pulmonary Disease.29/01/2015
AuthorisedEUCTR2014-002275-28-SIComparing the efficacy of tiotropium + olodaterol (5/5 µg) fixed dose combination (FDC) over tiotropium 5µg in reducing moderate to severe exacerbations in patients with severe to very severe Chronic Obstructive Pulmonary Disease.22/01/2015
AuthorisedEUCTR2014-002275-28-IEComparing the efficacy of tiotropium + olodaterol (5/5 µg) fixed dose combination (FDC) over tiotropium 5µg in reducing moderate to severe exacerbations in patients with severe to very severe Chronic Obstructive Pulmonary Disease.28/11/2014
AuthorisedEUCTR2014-002275-28-ITComparing the efficacy of tiotropium + olodaterol (5/5 µg) fixed dose combination (FDC) over tiotropium 5µg in reducing moderate to severe exacerbations in patients with severe to very severe Chronic Obstructive Pulmonary Disease.28/10/2014
AuthorisedEUCTR2014-002275-28-LTComparing the efficacy of tiotropium + olodaterol (5/5 µg) fixed dose combination (FDC) over tiotropium 5µg in reducing moderate to severe exacerbations in patients with severe to very severe Chronic Obstructive Pulmonary Disease.29/12/2014
AuthorisedEUCTR2014-002275-28-HUComparing the efficacy of tiotropium + olodaterol (5/5 µg) fixed dose combination (FDC) over tiotropium 5µg in reducing moderate to severe exacerbations in patients with severe to very severe Chronic Obstructive Pulmonary Disease.19/11/2014
AuthorisedEUCTR2014-002275-28-LVComparing the efficacy of tiotropium + olodaterol (5/5 µg) fixed dose combination (FDC) over tiotropium 5µg in reducing moderate to severe exacerbations in patients with severe to very severe Chronic Obstructive Pulmonary Disease.05/01/2015
AuthorisedEUCTR2014-002275-28-HRComparing the efficacy of tiotropium + olodaterol (5/5 µg) fixed dose combination (FDC) over tiotropium 5µg in reducing moderate to severe exacerbations in patients with severe to very severe Chronic Obstructive Pulmonary Disease.02/04/2015
AuthorisedEUCTR2014-002275-28-BEComparing the efficacy of tiotropium + olodaterol (5/5 µg) fixed dose combination (FDC) over tiotropium 5µg in reducing moderate to severe exacerbations in patients with severe to very severe Chronic Obstructive Pulmonary Disease.18/11/2014
AuthorisedEUCTR2014-002275-28-PTComparing the efficacy of tiotropium + olodaterol (5/5 µg) fixed dose combination (FDC) over tiotropium 5µg in reducing moderate to severe exacerbations in patients with severe to very severe Chronic Obstructive Pulmonary Disease.10/11/2014
AuthorisedEUCTR2014-002275-28-NLComparing the efficacy of tiotropium + olodaterol (5/5 µg) fixed dose combination (FDC) over tiotropium 5µg in reducing moderate to severe exacerbations in patients with severe to very severe Chronic Obstructive Pulmonary Disease.18/11/2014
AuthorisedEUCTR2014-002275-28-BGComparing the efficacy of tiotropium + olodaterol (5/5 µg) fixed dose combination (FDC) over tiotropium 5µg in reducing moderate to severe exacerbations in patients with severe to very severe Chronic Obstructive Pulmonary Disease.05/03/2015
RecruitingNCT02296138Comparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease.19/11/2014
28/10/2014
RecruitingNCT02273973
A Study of Neoadjuvant Letrozole + GDC-0032 Versus Letrozole + Placebo in Post-Menopausal Women With Breast Cancer (LORELEI)
22/10/2014
    
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.2 - Version history